Eyenovia announces poster presentation at arvo 2023

New york, april 24, 2023 (globe newswire) -- eyenovia, inc. (nasdaq: eyen), a pre-commercial ophthalmic technology company developing the optejet® delivery system for use both in connection with its own drug-device therapeutic programs for mydriasis, presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today announced a poster presentation at the association for research in vision and ophthalmology (arvo) 2023 annual meeting, which is being held april 23-27 in new orleans.
EYEN Ratings Summary
EYEN Quant Ranking